Impact of Second-Generation Antipsychotics and Perphenazine on Depressive Symptoms in a Randomized Trial of Treatment for Chronic Schizophrenia

BACKGROUND: According to the American Psychiatric Association Clinical Practice Guidelines for schizophrenia, second-generation antipsychotics may be specifically indicated for the treatment of depression in schizophrenia. We examined the impact of these medications on symptoms of depression using t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Psychiatry
Hauptverfasser: Addington, Donald E., Mohamed, Somaia, Rosenheck, Robert A., Davis, Sonia M., Stroup, Thomas Scott, McEvoy, Joseph P., Swartz, Marvin S., Lieberman, Jeffrey A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2010
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5052810/
https://ncbi.nlm.nih.gov/pubmed/20868641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.09m05258gre
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge